Spineway-VEOS FDA 510(k) Clearance – Ortho Spine News

  Spineway receives 510(k) clearance from the FDA for its VEOS spinal fixation system Ecully, October 19, 2023- Spineway Group, a specialist in innovative implants for the treatment of serious spinal conditions, is pleased to announce the recent 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VEOS Spinal Fixation System. This…